But this isn't biotech. It is tech and it's first indication is not FDA dependant.
20cents and under are where most of the long term holders are who have been holding since well before the FDA approval. It was about 23cents before approval and it seems to be currently holding well @25. Those who have been holding since below 10cents aren't going to lose their nerve mid-commercialization.
I don't think see this as going below 20c anytime soon, if at all. Especially with insurer codes imminent.
EIQ Price at posting:
25.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)